Skip to content

povidoneiodine pleurodesis

Effect of povidoneiodine pleurodesis in malignant pleural effusion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015071423202N1
Enrollment
1
Registered
2015-08-11
Start date
2015-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pleural effusion. Secondary malignant neoplasm of pleura

Interventions

thoracostomy tube will be inserted and after depletion of pleural effusion, pleurodesis will be done with 20cc of 20% povidoneiodine and 60 cc normal saline..
Treatment - Drugs
thoracostomy tube will be inserted and after depletion of pleural effusion, pleurodesis will be done with 20cc of 20% povidoneiodine and 60 cc normal saline.

Sponsors

Respiratory Center-University of Guilan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: inclusion criteria: patients with malignant and massive pleural effusion exclusion criteria:underline thyroid disease; underline renal disease; Lack of consent to participate in research

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Successful pleurodesis. Timepoint: 2 weeks- 4 weeks- 6 months after intervention. Method of measurement: chest X ray.

Secondary

MeasureTime frame
BUN. Timepoint: before intervention-first day after and 4 weeks later. Method of measurement: laboratory test.;Serum creatinin. Timepoint: before intervention-first day after and 4 weeks later. Method of measurement: laboratory test.;TSH. Timepoint: before intervention-first day after and 4 weeks later. Method of measurement: laboratory test.;T3. Timepoint: before intervention-first day after and 4 weeks later. Method of measurement: laboratory test.;T4. Timepoint: before intervention-first day after and 4 weeks later. Method of measurement: laboratory test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadi Kahrom

Guilan University od Medical Science

hadikahrom@yahoo.com+98 13 3354 2460

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026